Excellence in Scientific Discovery
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Inter-disciplinary teams of collaborative investigators partner to foster discovery, application and translation of scientific knowledge.
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Internal and external sources of support for both established cancer research programs and promising new ideas.
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
Education and professional development designed to train the next generation of cancer researchers and physicians.
National Cancer Institute Designation
In addition to providing grants and other support to cancer researchers at institutions around the country, the National Cancer Institute employs scientists who conduct basic, clinical, and population-based research, including the study of rare cancers and the translation of laboratory findings to the clinic.
More about our NCI Designation
October 17, 2022
New National Academy of Medicine members
Grace Lee, Crystal Mackall, Paul Mischel, Kari Nadeau, Anthony Oro and Krishna Shenoy are among the 100 members elected this year to the National Academy of Medicine.
October 6, 2022
Improving end-of-life care for kids
Research into medical decisions for children with terminal illnesses can be improved by sensitively tapping the expertise of families who have lost a child, according to Stanford Medicine experts.